WELL Health Technologies (TSE:WELL) PT Lowered to C$10.00

WELL Health Technologies (TSE:WELL) had its target price reduced by stock analysts at Stifel Nicolaus from C$11.00 to C$10.00 in a research note issued on Monday, BayStreet.CA reports. Stifel Nicolaus’ price target points to a potential upside of 173.97% from the stock’s current price.

WELL has been the subject of several other reports. Pi Financial upped their target price on shares of WELL Health Technologies from C$8.25 to C$8.50 in a research note on Wednesday, January 31st. Royal Bank of Canada set a C$5.50 target price on shares of WELL Health Technologies and gave the company an “outperform” rating in a research note on Tuesday, February 6th. Finally, CIBC lowered shares of WELL Health Technologies from an “outperform” rating to a “neutral” rating and lowered their price target for the company from C$5.50 to C$4.75 in a report on Monday, January 22nd. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of C$7.13.

WELL Health Technologies Price Performance

TSE:WELL opened at C$3.65 on Monday. The stock has a market cap of C$896.55 million, a P/E ratio of -185.00, a PEG ratio of -1.93 and a beta of 1.27. WELL Health Technologies has a one year low of C$3.41 and a one year high of C$5.94. The company has a fifty day moving average price of C$3.78 and a 200 day moving average price of C$3.84. The company has a debt-to-equity ratio of 50.38, a current ratio of 1.15 and a quick ratio of 1.02.

About WELL Health Technologies

WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.